Oxidative, multistep activation of the noncanonical NF-κB pathway via disulfide Bcl-3/p50 complex

被引:25
作者
Cristofanon, Silvia [1 ,2 ]
Morceau, Franck [2 ]
Scovassi, A. Ivana [3 ]
Dicato, Mario [2 ]
Ghibelli, Lina [1 ]
Diederich, Marc [2 ]
机构
[1] Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy
[2] Hop Kirchberg, Lab Biol Mol & Ecllulaire Canc, Fdn Rech Canc & Maladies Sang, L-2540 Luxembourg, Luxembourg
[3] Ist Genet Mol Consiglio Nazl Ric, Pavia, Italy
关键词
glutathione; Bcl-2; ROS; p38; GLUTATHIONE DEPLETION; MAP KINASE; NUCLEAR TRANSLOCATION; BCL-2; EXPRESSION; P50; HOMODIMERS; CELLS; APOPTOSIS; TRANSCRIPTION; BINDING; MODULATION;
D O I
10.1096/fj.07-104109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Buthionine sulfoximine ( BSO) is a well-known inhibitor of glutathione synthesis, producing slow glutathione ( GSH) depletion and oxidative stress; some "responder" cells avoid BSO-induced death by trans-activating the prosurvival protein Bcl-2. Here we show that BSO activates a noncanonical, inhibitory NF-kappa B- and p65-independent NF-kappa B pathway via a multistep process leading to the up-regulation of Bcl-2. The slow BSO-induced GSH depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a p50-p50 homodimer. The early phase, coinciding with substantial thiol depletion, produces a cytosolic preparative complex, consisting of p50 and its interactor Bcl-3 linked by interprotein disulfide bridges. The late phase, coinciding with reactive oxygen species production, is responsible, probably via p38 activation, for nuclear targeting of the complex and trans-activation of Bcl-2. Cristofanon, S., Morceau, F., Scovassi, A. I., Dicato, M., Ghibelli, L., Diederich, M. Oxidative, multistep activation of the noncanonical NF-kappa B pathway via disulfide Bcl-3/p50 complex. FASEB J. 23, 45-57 ( 2009)
引用
收藏
页码:45 / 57
页数:13
相关论文
共 43 条
[1]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[2]   Oxidative stress and nuclear factor-κB activation -: A reassessment of the evidence in the light of recent discoveries [J].
Bowie, A ;
O'Neill, LAJ .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (01) :13-23
[3]   NF-κB-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence [J].
Brasier, AR ;
Lu, MP ;
Hai, T ;
Lu, Y ;
Boldogh, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :32080-32093
[4]   Dual effect of oxidative stress on NF-κB activation in HeLa cells [J].
Byun, MS ;
Jeon, KI ;
Choi, JW ;
Shim, JY ;
Jue, DM .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2002, 34 (05) :332-339
[5]  
Casini A F, 1984, Toxicol Pathol, V12, P295
[6]   Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes [J].
Celli, A ;
Que, FG ;
Gores, GJ ;
LaRusso, NF .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1998, 275 (04) :G749-G757
[7]   Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis [J].
D'Alessio, M ;
De Nicola, M ;
Coppola, S ;
Gualandi, G ;
Pugliese, L ;
Cerella, C ;
Cristofanon, S ;
Civitareale, P ;
Ciriolo, MR ;
Bergamaschi, A ;
Magrini, A ;
Ghibelli, L .
FASEB JOURNAL, 2005, 19 (08) :1504-+
[8]   Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells [J].
D'Alessio, M ;
Cerella, C ;
Amici, C ;
Pesce, C ;
Coppola, S ;
Fanelli, C ;
De Nicola, M ;
Cristofanon, S ;
Clavarino, G ;
Bergamaschi, A ;
Magrini, A ;
Gualandi, G ;
Ghibelli, L .
FASEB JOURNAL, 2004, 18 (11) :1609-+
[9]   The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators [J].
Dechend, R ;
Hirano, F ;
Lehmann, K ;
Heissmeyer, V ;
Ansieau, S ;
Wulczyn, FG ;
Scheidereit, C ;
Leutz, A .
ONCOGENE, 1999, 18 (22) :3316-3323
[10]   The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways [J].
Dejardin, E ;
Droin, NM ;
Delhase, M ;
Haas, E ;
Cao, YX ;
Makris, C ;
Li, ZW ;
Karin, M ;
Ware, CF ;
Green, DR .
IMMUNITY, 2002, 17 (04) :525-535